The presence of CD8 T cells within the TME has been associated with improved tumor clearance and overall prognosis, often characterized by the concomitant presence of pro-inflammatory cytokines such as Type I IFN (Trujillo et al., 2018). This evidence concerns the gene CD8A and neoplasm.